CD40LG and myeloid sarcoma: This suggests that RF production may be related to underlying pathological mechanisms in at least some MS patients and show pathogen-specific IgM antibodies.32 Also, intrathecal IgM seems to respond more to treatment than IgG, suggesting a different origin of the antibody.33